Cargando…

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales:	Albers, HM, Wessels, JAM, Straaten, RJH van der, Brinkman, DMC, Suijlekom-Smit, LWA, Kamphuis, SSM, Girschick, HJ, Wouters, C, Schilham, MW, le Cessie, S, Huizinga, TWJ, ten Cate, R, Guchelaar, HJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334106/ http://dx.doi.org/10.1186/1546-0096-6-S1-P46

Ejemplares similares

The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis
por: Albers, HM, et al.
Publicado: (2008)

Association of the CD226 (DNAM-1) Gly307Ser polymorphism with juvenile idiopathic arthritis
por: Reinards, THCM, et al.
Publicado: (2011)

Association of the CCR5Δ32 variant with juvenile idiopathic arthritis in a meta-analysis
por: Reinards, THCM, et al.
Publicado: (2011)

Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)
por: Muller, PCE Hissink, et al.
Publicado: (2011)

PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis
por: Reinards, TH, et al.
Publicado: (2013)

Development of a web-based register for the Dutch national study on biologicals in juvenile idiopathic arthritis: http://www.abc-register.nl
por: Prince, FHM, et al.
Publicado: (2008)

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
por: Prince, FHM, et al.
Publicado: (2008)

Autoantibodies to GPI are predominantly present in extra-articular complications of human rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2003)

CD25(+ )regulatory T cells can be used therapeutically in collagen-induced arthritis
por: Morgan, ME, et al.
Publicado: (2004)

Activated CD27+ and CD27- memory B cells accumulate in the joints of patients with juvenile idiopathic arthritis
por: Morbach, H, et al.
Publicado: (2008)

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
por: Martini, G, et al.
Publicado: (2008)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

Elevated IL-16 level is a non-genetic characteristic of patients with severe systemic lupus erythematosus
por: Lard, LR, et al.
Publicado: (2001)

Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosage
por: Gallo, G, et al.
Publicado: (2016)

Targeted therapies in rheumatoid arthritis: Focus on rituximab
por: Teng, YKO, et al.
Publicado: (2007)

Juvenile chronic non-bacterial osteomyelitis (CNO): Long term course of disease and response to treatment in a large institutional cohort
por: Schwarz, T, et al.
Publicado: (2015)

The Psychosocial Impact of the COVID-19 Pandemic on Chronic Care Patients
por: Gruiskens, Jeroen R.J.H., et al.
Publicado: (2023)

Pro-MMP levels and severity of RA
por: Tchetverikov, I, et al.
Publicado: (2003)

Fibroblast-like synoviocytes obtained from different joints at different times from one patient show similar invasiveness in vitro
por: Tolboom, TCA, et al.
Publicado: (2003)

Association between TNF -308A and systemic lupus erythematosus in relation to HLA-DR3 and six microsatellite markers on the short arm of chromosome VI
por: van der Linden, MW, et al.
Publicado: (2001)

Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)
por: Dougados, Maxime, et al.
Publicado: (2013)

PReS-FINAL-2160: Intestinal microbiome in polyarticular juvenile idiopathic arthritis: a pilot study
por: Hissink Muller, PC, et al.
Publicado: (2013)

Factors influencing adenoviral gene transfer
por: Huizinga, TWJ, et al.
Publicado: (2001)

PReS-FINAL-2052: Costs of biologics in juvenile idiopathic arthritis: past, present and future
por: Prince, FH, et al.
Publicado: (2013)

Patterns of clinical joint inflammation in juvenile idiopathic arthritis
por: Heckert, Sascha L, et al.
Publicado: (2023)

Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia
por: Girschick, HJ, et al.
Publicado: (2006)

Fibroblast-like synoviocytes from rheumatoid arthritis patients express less flice-inhibitory protein than FLS from osteoarthritis, trauma and prosthesis loosening patie
por: Tolboom, TCA, et al.
Publicado: (2002)

A single nucleotide polymorphism on the IL-10 locus defines an expression polymorphism and a possible risk factor to develop RA
por: Lard, LR, et al.
Publicado: (2001)

Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?
por: Hissink Muller, Petra C. E., et al.
Publicado: (2018)

Long term functional outcome and quality of life of patients with refractory juvenile idiopathic arthritis treated with etanercept: results of the dutch arthritis and biologicals in children register
por: Anink, Janneke, et al.
Publicado: (2014)

Altered composition of CD97 splice variants in rheumatoid synovial tissue
por: van Gaalen, FA, et al.
Publicado: (2005)

Hepatitis B virus X protein interacts with β5 subunit of heterotrimeric guanine nucleotide binding protein
por: Lwa, Siew Hui, et al.
Publicado: (2005)

The effect of repeated methotrexate injections on the quality of life of children with rheumatic diseases
por: Jacobse, Justin, et al.
Publicado: (2018)

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19
por: Swen, J. J., et al.
Publicado: (2011)

Early treatment of recent-onset rheumatoid arthritis patients impairs the effect of HLA class II antigents on the progression of joint destruction
por: Lard, LR, et al.
Publicado: (2001)

Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
por: Strand, Vibeke, et al.
Publicado: (2016)

Regarding: ‘Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array’
por: Pander, J, et al.
Publicado: (2010)

PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register
por: Otten, MH, et al.
Publicado: (2013)

PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis
por: Anink, J, et al.
Publicado: (2013)

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
por: Fleischmann, Roy M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2k2431drf4hpebmggrq3gnbd8r